Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Tissue Biopsy”

812 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 812 results

Early research (Phase 1)UnknownNCT03442543
What this trial is testing

Preoperative Localization of Sentinel Lymph Node in Breast Cancer Patients By Novel Computed Tomography-Lymphography Guided Technique

Who this might be right for
Breast Cancer
Mansoura University 50
Not applicableUnknownNCT02992990
What this trial is testing

Bladder Tumor Biopsy Study to Improve Preoperative Determination of Stage and Grade

Who this might be right for
Bladder Cancer
Baylor College of Medicine 30
Very early researchEnded earlyNCT03927274
What this trial is testing

Intratumorally-Administered Topotecan Using Convection-Enhanced Delivery in Patients With Grade III/ IV Glioma

Who this might be right for
Glioma of Brain
H. Lee Moffitt Cancer Center and Research Institute 3
Not applicableStudy completedNCT04753229
What this trial is testing

Ki67 Proliferation Index of Pancreatic Neuroendocrine Neoplasia

Who this might be right for
Neuroendocrine Tumors
Institut Paoli-Calmettes 50
Not applicableStudy completedNCT04256161
What this trial is testing

Measurements of Sexual Steroids' Concentrations in Prostatic Tissue

Who this might be right for
Bladder Cancer
Hopital Foch 24
Not applicableEnded earlyNCT02540083
What this trial is testing

Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis Compared to Mammography

Who this might be right for
Breast CancerTumors, Breast
GE Healthcare 94
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Not applicableLooking for participantsNCT04510129
What this trial is testing

Cancer Biospecimen Collection Study

Who this might be right for
Cancer of Head and NeckLung Cancer, Nonsmall CellSmall-cell Lung Cancer+8 more
Cofactor Genomics, Inc. 1,650
Not applicableStudy completedNCT01885741
What this trial is testing

Study to Demonstrate the Preliminary Safety and Effectiveness of IPBS in Performing MRI-Guided Targeting and Intervention of Breast Tissue in Female Patients Indicated for MRI-Guided Breast Biopsy

Who this might be right for
Breast Cancer ScreeningMRI Guided Breast BiopsyBreast Cancer Diagnosis
McMaster University 9
Not applicableStudy completedNCT05665894
What this trial is testing

Vacuum-Assisted Evacuation (VAE) Of Symptomatic and/or Voluminous Breast Haematomas Following Surgeries And Percutaneous Procedures: a Retrospective Analysis

Who this might be right for
Breast HaematomaBreast CancerBreast Diseases
University of Rome Tor Vergata 15
Not applicableActive Not RecruitingNCT06744075
What this trial is testing

Study of the Clearance of Minimal Residual Disease Measured at the End of First-line Treatment in Patients With Lymphoma

Who this might be right for
B-cell LymphomaHodgkin Lymphoma
Centre Henri Becquerel 108
Large-scale testing (Phase 3)Looking for participantsNCT06704945
What this trial is testing

No Axillary Surgical Treatment in Clinically Lymph Node Negative Patients on Ultrasonography After Neoadjuvant Chemotherapy

Who this might be right for
Breast CancerNeoadjuvant TherapySentinel Lymph Node Biopsy
Seoul National University Hospital 464
Not applicableStudy completedNCT04817501
What this trial is testing

Phenotypic Spectrum of CTCs in Tumors of the Female Reproductive System

Who this might be right for
Breast CancerOvarian CancerEndometrial Cancer
Tomsk National Research Medical Center of the Russian Academy of Sciences 150
Testing effectiveness (Phase 2)UnknownNCT04651946
What this trial is testing

Cell-free DNA Methylation for Epithelial Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerDNA MethylationBenign Ovarian Tumor+4 more
Lei Li 400
Testing effectiveness (Phase 2)Active Not RecruitingNCT02407405
What this trial is testing

MEK 1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis 1 (NF1)Plexiform Neurofibromas (PN)
National Cancer Institute (NCI) 36
Not applicableUnknownNCT05814224
What this trial is testing

Monitoring luminAl Breast Cancer Through the Evaluation of Mutational and epiGeNEtic alteraTIons of Circulating ESR1 DNA

Who this might be right for
Hormone Receptor Positive Breast CarcinomaBreast NeoplasmsNeoplasms, Breast+4 more
Centro di Riferimento Oncologico - Aviano 164
Large-scale testing (Phase 3)Looking for participantsNCT04722692
What this trial is testing

Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ

Who this might be right for
DCISBreast CancerBreast Neoplasms+1 more
Uppsala University 500
Testing effectiveness (Phase 2)UnknownNCT02294565
What this trial is testing

VST-1001 (Dilute Fluorescein) for Lymphatic Mapping & Localization of Lymph Nodes in Patients With Breast Cancer

Who this might be right for
Breast Cancer
Vestan, Inc. 147
Not applicableLooking for participantsNCT04608357
What this trial is testing

Integrated Patient Avatars for Guiding Systemic Therapy Treatments in Metastatic Breast Cancer Patients

Who this might be right for
Breast CancerBreast NeoplasmsMetastatic Breast Cancer+1 more
Sunnybrook Health Sciences Centre 25
Not applicableEnded earlyNCT01956552
What this trial is testing

Changes in Phenotype and Genotype of Breast Cancers During the Metastatic Process and Optimization of Therapeutic Targeting (ESOPE)

Who this might be right for
Metastatic Breast Cancer
Institut Curie 130
Load More Results